Senior ML Research Scientist
Rad AI- Full Time
- Senior (5 to 8 years)
Employment Type: Full-Time Location Type: Remote Salary: [Not Specified]
Iambic Therapeutics is seeking a Machine Learning Scientist to enhance our multimodal transformer, Enchant, by integrating omics signals such as genomics, transcriptomics, proteomics, and metabolomics. This role will primarily focus on target selection and biomarker discovery. The successful candidate will be responsible for creating robust data pipelines, curating benchmarking datasets, and developing models that combine multi-omics information with existing context in Enchant. A strong understanding of causal experimental design and the interactions among diverse molecular modalities is crucial. While the position is remote, candidates located in Bristol are preferred.
Iambic is a clinical-stage life-science and technology company dedicated to developing novel medicines through its AI-driven discovery and development platform. Founded in 2020 and based in San Diego, Iambic has assembled a world-class team comprising pioneering AI experts and seasoned drug hunters. The Iambic platform has a proven track record of delivering new drug candidates to human clinical trials with exceptional speed, across various target classes and mechanisms of action. The company is advancing a pipeline of potentially best-in-class and first-in-class clinical assets, both internally and through partnerships, to address critical unmet patient needs.
Learn more about Iambic's team, platform, pipeline, and partnerships at iambic.ai.
Iambic's mission is to deliver better medicines through innovations in AI-based discovery technologies. The company fosters a culture that is significantly enriched by the diversity of its people, encompassing differences in background, culture, national origin, religion, sexual orientation, and life experiences. Iambic is committed to building an inclusive environment where a diverse group of talented individuals collaborate to discover therapeutics and create groundbreaking technologies.
Iambic Therapeutics offers a competitive compensation package, pension contributions, and flexible holiday allowances. Our UK office provides a modern and collaborative work environment situated in the heart of Bristol.
Develops therapies for CNS disorders
Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain, which helps regulate mood. This drug has shown positive results in clinical trials and has received special FDA status to speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.